Adductor Canal Block Versus Lumbar Plexus Block for Post Operative Pain Management After Total Knee Replacement
NCT ID: NCT02853669
Last Updated: 2016-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
26 participants
INTERVENTIONAL
2016-07-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This prospective double-blinded randomized controlled trial is comparing ultrasound guided adductor canal block (ACB) versus ultrasound-guided lumbar plexus block (LPB) in patients undergoing total knee arthroplasty aiming at decreasing post-operative pain, helping in early mobilization and better physiotherapy.
This study hypothesizes that ACB, compared with LPB, will exhibit less motor, weakness, fewer opioids consumption with the same or better pain score.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adductor Canal Block (ACB) Versus ACB /Saphenous Block in Patients Undergoing Anterior Cruciate Ligament Repair
NCT04443634
Ultrasound-Guided Adductor Canal Block for Total Knee Arthroplasty Surgery
NCT04189640
Adductor Canal Block With IPACK Versus Genicular Nerves Block With IPACK for Post-operative Analgesia
NCT07258277
Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block
NCT02548104
Comparison Between (GNB) Combined With (IPACK) Block Versus ACB in TKA
NCT06423339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study hypothesizes that ACB, compared with LPB, will exhibit less motor, weakness, fewer opioids consumption with the same or better pain score.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group (A) lumber plexus block
Ultrasound-guided Lumber plexus Block (30 cc of 0.25% of bupivacaine, via a 22-gauge 2-inch Stimuplex A needle) with nerve stimulator confirmation.
Ultrasound-guided Lumber Plexus Block
(30 cc of 0.25% of bupivacaine, via a 22-gauge 2-inch Stimuplex A needle) with nerve stimulator confirmation. The type of motor response (e.g., quadriceps, patellar) and the minimum current needed were recorded. Ultrasound pictures (preinjection and postinjection) were obtained to verify proper local anesthetic placement.
Group (B) adductor canal block
ultrasound-guided Adductor Canal Block (15 cc of 0.5% of bupivacaine)
adductor canal block
ultrasound-guided Adductor Canal Block (15 cc of 0.5% of bupivacaine)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound-guided Lumber Plexus Block
(30 cc of 0.25% of bupivacaine, via a 22-gauge 2-inch Stimuplex A needle) with nerve stimulator confirmation. The type of motor response (e.g., quadriceps, patellar) and the minimum current needed were recorded. Ultrasound pictures (preinjection and postinjection) were obtained to verify proper local anesthetic placement.
adductor canal block
ultrasound-guided Adductor Canal Block (15 cc of 0.5% of bupivacaine)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age more than 25 and less than 80 were included
Exclusion Criteria
* ASA III, IV
* Age less than 25 or more than 80
* Dementia
* Deafness
* Psychological disease
* Difficult to communicate
* Cannot lay flat
* INR more than 1.5
* Low platelets (less than 100000/ml3) or with significant coagulopathy
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hassan Mohamed Ali
lecturer in anesthesia department Cairo university
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hassan Ali, LECTURER
Role: STUDY_DIRECTOR
Anesthesia department, faculty of medicine ,Cairo university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, Giza Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
adductor canal
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.